Abstract
Objective — to evaluate the clinical and prognostic significance of routine coagulation profile parameters as markers of severe proliferative diabetic retinopathy (PDR) and rapid diabetic retinopathy (DR) progression, and to establish practical cut-off values for risk stratification in patients with type 2 diabetes mellitus (T2DM). Materials and methods. A prospective cohort study was conducted involving 358 patients with T2DM and DR. According to the World Health Organization criteria (reclassified for the study), patients were categorized into non-proliferative/pre-proliferative DR (n=285) and PDR (n=73) groups. Based on 1 — 2 year follow-up dynamics, patients were classified into groups of non/slow progression (Grade 0 — 1, n=209) and rapid progression (Grade 2, n=149). The coagulation profile, including prothrombin time (PT), International Normalized Ratio (INR), activated partial thromboplastin time (APTT), fibrinogen, activated recalcification time (ART), prothrombin index (PTI), and thrombin time (TT), was assessed using standardized methods. Logistic regression and Receiver Operating Characteristic (ROC) analysis with Youden’s index calculation were performed. Results. Patients with PDR and those with rapid progression exhibited significantly higher levels of fibrinogen, prolonged PT, TT, and ART compared to controls (p < 0.01), while INR and APTT showed no significant differences. In univariate logistic regression, PT, Quick’s prothrombin, fibrinogen, ART, PTI, and TT were significant predictors of both severe DR and rapid progression. These associations persisted after adjustment for age, sex, T2DM duration, and blood pressure but lost statistical significance after further adjustment for glycated hemoglobin (HbA1c) (p ≥ 0.145), indicating the confounding/mediating role of glycemic control. ROC analysis revealed moderate discriminative ability for individual markers (AUC 0.60 — 0.66). However, the optimal cut-offs derived (e.g., ART > 75 s, fibrinogen > 459 mg/dL) demonstrated high specificity (> 90%) for identifying high-risk phenotypes. Conclusions. Severe DR and rapid disease progression in T2DM are associated with a prothrombotic profile characterized by elevated fibrinogen and altered clotting kinetics. These coagulation deviations are closely linked to poor glycemic control, serving as surrogate markers of metabolic decompensation rather than independent risk factors. Despite moderate overall sensitivity, the identified cut-off values for fibrinogen and recalcification time possess high specificity, supporting their potential clinical utility as «rule-in» criteria for prioritizing patients requiring intensified ophthalmological monitoring.